Answers are grounded in this paper and cite their sources.
Background Sepsis-associated pulmonary infection in intubated patients remains a major diagnostic challenge in critical care, with conventional culture limited by low sensitivity, long turnaround times, and inability to detect certain pathogens. Metagenomic next-generation sequencing (mNGS) offers unbiased, rapid pathogen detection. This study aimed to compare mNGS with conventional culture in terms of detection rates, turnaround time, and clinical impact on antimicrobial therapy. Methods A retrospective study was conducted on 92 intubated patients with ventilator-associated pneumonia (102 bronchoalveolar lavage fluid samples). All samples were tested simultaneously by mNGS and conventional bacterial/fungal culture. Detection rates, turnaround times, microbial species distribution, and the impact of mNGS results on antimicrobial modifications were assessed. Stratified analyses by patient outcome (improvement vs death) were performed to evaluate the association between mNGS-guided modifications and clinical prognosis. Results mNGS demonstrated significantly higher detection rates for bacteria (71.6% vs 52.0%, p < 0.001) and fungi (62.8% vs 42.2%, p < 0.001) compared with conventional culture. mNGS also detected viruses in 62.8% of samples. Turnaround time was markedly shorter for mNGS (mean 1.50 days) than for bacterial culture (2.94 days), fungal culture (4.67 days), and tuberculosis culture (23.5 days for the two samples tested, range 22–25 days). Based on mNGS findings in evaluable cases (n = 71), antibacterial therapy was modified in 71.8% of cases, while antifungal and antiviral modifications occurred in 31.0% and 9.9%, respectively. Stratified analysis showed that improved patients had consistently higher proportions of mNGS-guided modifications than deceased patients across bacterial (47.37% vs 34.44%) and fungal (52.63% vs 37.50%) infections, though differences were not statistically significant. Conclusions Compared with conventional culture, mNGS offers higher detection rates and faster turnaround, facilitating rapid diagnosis of complex infections in critically ill patients. In the context of sepsis management in critical care, mNGS may serve as a rapid diagnostic adjunct to guide early targeted antimicrobial therapy. However, its clinical application for antibiotic guidance must balance these advantages against interpretive challenges and the need for clinical correlation. The potential prognostic benefit of mNGS-guided therapy, particularly in bacterial and fungal infections, warrants further investigation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: